Testing effectiveness (Phase 2)Study completedNCT00494442
What this trial is testing
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer
Who this might be right for
Ovarian Neoplasm
AstraZeneca 58